This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Chinese Academy of Medical Sciences. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Hanjun Qin: Innovator in Vaccine Development
Introduction
Hanjun Qin is a prominent inventor based in Beijing, China. He has made significant contributions to the field of vaccine development, particularly through his innovative research and patents. His work focuses on recombinant gene sequences that have the potential to enhance vaccine efficacy.
Latest Patents
Hanjun Qin holds a patent for a recombinant chemokine-antigen vaccine. This invention involves a recombinant gene sequence that comprises the human SLC gene, an antigen gene, and an IgG1-Fc fragment gene. The SLC gene is linked upstream to the antigen gene, while the IgG1-Fc fragment is linked downstream to the antigen gene. This invention also relates to the application of the recombinant gene sequence in the preparation of gene vaccines. He has 1 patent to his name.
Career Highlights
Hanjun Qin is affiliated with the Chinese Academy of Medical Sciences, where he conducts his research. His work has been instrumental in advancing the understanding of vaccine development and its applications in medical science.
Collaborations
Some of his notable coworkers include Dongmei Wang and Chen Lin, who have collaborated with him on various research projects.
Conclusion
Hanjun Qin's innovative work in vaccine development showcases his dedication to advancing medical science. His contributions through patents and research continue to have a significant impact in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile